Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 20 | 2025 | 173 | 8.560 |
Why?
|
| Alzheimer Disease | 28 | 2025 | 1001 | 5.590 |
Why?
|
| Peptide Fragments | 15 | 2025 | 307 | 3.630 |
Why?
|
| Insulin | 7 | 2025 | 258 | 2.960 |
Why?
|
| Endothelial Cells | 8 | 2025 | 329 | 2.190 |
Why?
|
| Mice, Transgenic | 11 | 2025 | 665 | 2.060 |
Why?
|
| Brain | 14 | 2025 | 1472 | 1.760 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2024 | 32 | 1.750 |
Why?
|
| Endocytosis | 5 | 2025 | 118 | 1.460 |
Why?
|
| Cerebral Amyloid Angiopathy | 4 | 2014 | 17 | 1.170 |
Why?
|
| Nanoparticles | 4 | 2018 | 460 | 1.090 |
Why?
|
| Mice | 22 | 2025 | 6644 | 1.070 |
Why?
|
| Protein Transport | 6 | 2020 | 296 | 1.040 |
Why?
|
| Animals | 31 | 2025 | 16992 | 0.970 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2025 | 299 | 0.970 |
Why?
|
| Neurons | 5 | 2018 | 1263 | 0.960 |
Why?
|
| Up-Regulation | 3 | 2024 | 536 | 0.920 |
Why?
|
| Chitosan | 4 | 2013 | 53 | 0.890 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 587 | 0.810 |
Why?
|
| Glucose | 1 | 2025 | 244 | 0.810 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2025 | 384 | 0.800 |
Why?
|
| Insulin Resistance | 1 | 2024 | 201 | 0.760 |
Why?
|
| Signal Transduction | 5 | 2025 | 2157 | 0.750 |
Why?
|
| Scopolamine | 2 | 2020 | 5 | 0.750 |
Why?
|
| Humans | 30 | 2025 | 43102 | 0.630 |
Why?
|
| Clathrin | 1 | 2019 | 21 | 0.600 |
Why?
|
| Apolipoprotein A-I | 1 | 2019 | 24 | 0.600 |
Why?
|
| Antiemetics | 1 | 2018 | 8 | 0.580 |
Why?
|
| Solid Phase Extraction | 1 | 2018 | 13 | 0.580 |
Why?
|
| Cholesterol | 1 | 2019 | 232 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 1869 | 0.530 |
Why?
|
| Cell Line | 5 | 2021 | 1410 | 0.520 |
Why?
|
| Endothelium | 3 | 2023 | 28 | 0.520 |
Why?
|
| Brain Chemistry | 1 | 2017 | 141 | 0.510 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 277 | 0.490 |
Why?
|
| Aging | 1 | 2022 | 783 | 0.490 |
Why?
|
| Drug Carriers | 2 | 2010 | 174 | 0.480 |
Why?
|
| PC12 Cells | 5 | 2018 | 93 | 0.470 |
Why?
|
| Olfactory Mucosa | 2 | 2005 | 19 | 0.460 |
Why?
|
| Iodine Radioisotopes | 3 | 2024 | 38 | 0.450 |
Why?
|
| Endothelium, Vascular | 2 | 2024 | 263 | 0.450 |
Why?
|
| Receptor, Insulin | 3 | 2024 | 25 | 0.410 |
Why?
|
| Rats | 7 | 2019 | 3735 | 0.410 |
Why?
|
| Acrylic Resins | 1 | 2013 | 13 | 0.400 |
Why?
|
| Male | 11 | 2025 | 23409 | 0.400 |
Why?
|
| Vaginosis, Bacterial | 1 | 2013 | 8 | 0.400 |
Why?
|
| Gels | 1 | 2013 | 45 | 0.400 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 1596 | 0.390 |
Why?
|
| Biological Transport | 4 | 2025 | 204 | 0.380 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 63 | 0.380 |
Why?
|
| Models, Biological | 3 | 2024 | 712 | 0.360 |
Why?
|
| Amyloid | 2 | 2012 | 65 | 0.360 |
Why?
|
| Nanostructures | 1 | 2014 | 161 | 0.360 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2011 | 12 | 0.350 |
Why?
|
| Biofilms | 1 | 2013 | 184 | 0.340 |
Why?
|
| Cells, Cultured | 4 | 2025 | 1621 | 0.330 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 306 | 0.330 |
Why?
|
| Cattle | 5 | 2013 | 498 | 0.320 |
Why?
|
| Fatty Alcohols | 1 | 2010 | 9 | 0.320 |
Why?
|
| Skin Absorption | 1 | 2010 | 16 | 0.320 |
Why?
|
| Contrast Media | 2 | 2008 | 103 | 0.310 |
Why?
|
| Melatonin | 1 | 2010 | 82 | 0.300 |
Why?
|
| Hippocampus | 2 | 2010 | 594 | 0.300 |
Why?
|
| Chlorpheniramine | 2 | 2005 | 2 | 0.290 |
Why?
|
| Skin | 1 | 2010 | 187 | 0.290 |
Why?
|
| Mutation | 2 | 2012 | 1177 | 0.270 |
Why?
|
| Permeability | 3 | 2019 | 67 | 0.260 |
Why?
|
| Administration, Cutaneous | 3 | 2020 | 48 | 0.260 |
Why?
|
| Swine | 2 | 2025 | 212 | 0.260 |
Why?
|
| Lysosomes | 3 | 2019 | 86 | 0.260 |
Why?
|
| Positron-Emission Tomography | 2 | 2024 | 93 | 0.250 |
Why?
|
| Putrescine | 1 | 2006 | 27 | 0.240 |
Why?
|
| Triprolidine | 1 | 2005 | 1 | 0.240 |
Why?
|
| Hydroxyzine | 1 | 2005 | 2 | 0.240 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2025 | 17 | 0.230 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2025 | 20 | 0.230 |
Why?
|
| Kinetics | 3 | 2020 | 695 | 0.220 |
Why?
|
| Lipoproteins, HDL | 1 | 2024 | 48 | 0.210 |
Why?
|
| Tyrphostins | 1 | 2024 | 15 | 0.210 |
Why?
|
| Piperazines | 1 | 2005 | 120 | 0.210 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2014 | 16 | 0.210 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2024 | 28 | 0.210 |
Why?
|
| tau Proteins | 1 | 2024 | 186 | 0.200 |
Why?
|
| Virus Internalization | 1 | 2023 | 36 | 0.200 |
Why?
|
| Protein Isoforms | 1 | 2023 | 139 | 0.190 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2018 | 465 | 0.190 |
Why?
|
| Gallium Radioisotopes | 1 | 2022 | 3 | 0.190 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 115 | 0.180 |
Why?
|
| Peptides | 1 | 2024 | 372 | 0.170 |
Why?
|
| Gadolinium | 2 | 2014 | 30 | 0.170 |
Why?
|
| Female | 8 | 2024 | 24698 | 0.170 |
Why?
|
| Injections, Intravenous | 2 | 2018 | 67 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1766 | 0.160 |
Why?
|
| Surface Plasmon Resonance | 2 | 2010 | 42 | 0.160 |
Why?
|
| Age Factors | 1 | 2022 | 1154 | 0.140 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 1180 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1542 | 0.140 |
Why?
|
| Dogs | 1 | 2018 | 204 | 0.140 |
Why?
|
| Diffusion | 2 | 2010 | 63 | 0.140 |
Why?
|
| Solubility | 2 | 2010 | 139 | 0.130 |
Why?
|
| Tissue Distribution | 1 | 2017 | 240 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 760 | 0.120 |
Why?
|
| Presenilin-1 | 2 | 2007 | 28 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 241 | 0.120 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2007 | 95 | 0.120 |
Why?
|
| Aged | 2 | 2024 | 8214 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1081 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1124 | 0.110 |
Why?
|
| Gene Expression | 1 | 2017 | 701 | 0.110 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 59 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 94 | 0.100 |
Why?
|
| Adhesives | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 1 | 2013 | 3 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 23 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 51 | 0.100 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2012 | 15 | 0.090 |
Why?
|
| Endosomes | 1 | 2012 | 33 | 0.090 |
Why?
|
| Histidine | 1 | 2012 | 43 | 0.090 |
Why?
|
| Fluorescence Polarization | 1 | 2012 | 28 | 0.090 |
Why?
|
| Caveolin 1 | 1 | 2012 | 33 | 0.090 |
Why?
|
| Microscopy, Atomic Force | 1 | 2012 | 61 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2013 | 136 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 160 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2012 | 108 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 423 | 0.090 |
Why?
|
| Immunoglobulin Fragments | 2 | 2008 | 12 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 53 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 306 | 0.080 |
Why?
|
| Chemical Phenomena | 1 | 2010 | 56 | 0.080 |
Why?
|
| Cell Compartmentation | 1 | 2009 | 12 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 184 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 758 | 0.070 |
Why?
|
| Heterocyclic Compounds | 1 | 2008 | 23 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 206 | 0.070 |
Why?
|
| Polyamines | 1 | 2008 | 32 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 71 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 114 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 2676 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1723 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2007 | 144 | 0.060 |
Why?
|
| Etoposide | 1 | 2005 | 21 | 0.060 |
Why?
|
| Adult | 2 | 2020 | 13872 | 0.060 |
Why?
|
| Nasal Mucosa | 1 | 2005 | 35 | 0.060 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2005 | 58 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 105 | 0.060 |
Why?
|
| Autopsy | 1 | 2024 | 48 | 0.060 |
Why?
|
| Motor Neurons | 1 | 2005 | 90 | 0.050 |
Why?
|
| Motor Cortex | 1 | 2005 | 54 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 388 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2005 | 570 | 0.050 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2022 | 5 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2005 | 561 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1063 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2005 | 1003 | 0.040 |
Why?
|
| Autophagy | 1 | 2019 | 140 | 0.030 |
Why?
|
| Proteobacteria | 1 | 2017 | 9 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 2853 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2008 | 197 | 0.030 |
Why?
|
| Apoptosis | 1 | 2005 | 1568 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 115 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 203 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2008 | 259 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3156 | 0.030 |
Why?
|
| Protein Binding | 2 | 2009 | 1082 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2009 | 32 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 12222 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 5080 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 6081 | 0.020 |
Why?
|
| Chromatography, Paper | 1 | 2008 | 1 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 13 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 2007 | 13 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2007 | 65 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2007 | 109 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 44 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 934 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 73 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 458 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2005 | 13 | 0.010 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2005 | 3 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 84 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 148 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 158 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 227 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 462 | 0.010 |
Why?
|
| Disease Progression | 1 | 2005 | 667 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 986 | 0.010 |
Why?
|